Identification of a potential novel Staphylococcus species via genomic sequencing: A neonatal infection case report

Coagulase-negative Staphylococci (CoNS) are common symbiotic Gram-positive bacteria colonizing human skin and mucous membranes with lower virulence than Staphylococcus aureus. As crucial pathogens of neonatal infections, they often harbor multiple drug resistance genes and can induce neonatal pneumonia, sepsis, suppurative meningitis, and other clinical manifestations.

A preterm neonate at 29⁺¹ weeks' gestation complicated by respiratory distress syndrome and pneumonia received empirical ceftazidime and penicillin for 8 days. The condition initially improved but suddenly deteriorated on postnatal day 17 with septic shock, fever, and anemia. Routine tests suggested Staphylococcus capitis infection, and targeted anti-infective and supportive treatments relieved symptoms. Given the inconsistenty between the infection severity and that of typical Staphylococcus infections, metagenomic next-generation sequencing (mNGS) and whole-genome sequencing (WGS) were further performed, identifying a potential novel Staphylococcus species closely related to Staphylococcus warneri. Nevertheless, the origin of this potential novel species remains unclear, which needs further verification.

For neonates with sudden clinical deterioration, intractable infection or ambiguous conventional microbial results, mNGS and WGS facilitate accurate pathogen identification and treatment adjustment. This potential novel strain discovery highlights the importance of enhanced vigilance against bacterial multidrug resistance and the emergence of potential novel pathogens in neonatal care.